DK0454089T3 - Percutant absorberbart eperison- eller tolperisonpræparat - Google Patents

Percutant absorberbart eperison- eller tolperisonpræparat

Info

Publication number
DK0454089T3
DK0454089T3 DK91106600.9T DK91106600T DK0454089T3 DK 0454089 T3 DK0454089 T3 DK 0454089T3 DK 91106600 T DK91106600 T DK 91106600T DK 0454089 T3 DK0454089 T3 DK 0454089T3
Authority
DK
Denmark
Prior art keywords
tolperisone
eperison
preparation
percutaneously absorbable
salt
Prior art date
Application number
DK91106600.9T
Other languages
Danish (da)
English (en)
Inventor
Masato Azuma
Tsutomu Negama
Mitsuhiro Yoshida
Hiroyuki Fujimori
Original Assignee
Eisai Co Ltd
Seikisui Chemical Co Ltd
Sansho Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Seikisui Chemical Co Ltd, Sansho Co filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DK0454089T3 publication Critical patent/DK0454089T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK91106600.9T 1990-04-27 1991-04-24 Percutant absorberbart eperison- eller tolperisonpræparat DK0454089T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11279290 1990-04-27

Publications (1)

Publication Number Publication Date
DK0454089T3 true DK0454089T3 (da) 1994-09-19

Family

ID=14595632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91106600.9T DK0454089T3 (da) 1990-04-27 1991-04-24 Percutant absorberbart eperison- eller tolperisonpræparat

Country Status (11)

Country Link
EP (1) EP0454089B1 (ko)
JP (1) JP3170304B2 (ko)
KR (1) KR930007407B1 (ko)
CN (1) CN1049817C (ko)
AT (1) ATE109980T1 (ko)
CA (1) CA2041330C (ko)
DE (1) DE69103459T2 (ko)
DK (1) DK0454089T3 (ko)
ES (1) ES2058977T3 (ko)
MY (1) MY115126A (ko)
PT (1) PT97505B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JPH06247846A (ja) * 1993-02-22 1994-09-06 Toko Yakuhin Kogyo Kk 塩酸リトドリンの経皮吸収製剤用組成物
EP0705097B2 (en) 1993-06-25 2004-01-14 Alza Corporation Incorporating poly-n-vinyl amide in a transdermal system
PL181582B1 (pl) * 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
JP5209433B2 (ja) * 2007-10-19 2013-06-12 日東電工株式会社 貼付製剤
WO2009075258A1 (ja) * 2007-12-10 2009-06-18 Cosmed Pharmaceutical Co., Ltd. 経皮吸収製剤
JP5631854B2 (ja) * 2010-12-13 2014-11-26 久光製薬株式会社 医薬組成物および貼付剤
KR20140118410A (ko) * 2013-03-29 2014-10-08 초당약품공업 주식회사 저장 및 pH 안정성이 개선된 에페리손 의약 조성물
KR20230109782A (ko) * 2016-07-27 2023-07-20 코리움, 엘엘씨 아민 약물의 나트륨 바이카보네이트 제자리 전환 구동된경피성 전달
WO2020086046A2 (en) * 2018-10-26 2020-04-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Topical compositions comprising tolperisone and flurbiprofen combination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
JPH0720866B2 (ja) * 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤

Also Published As

Publication number Publication date
CN1049817C (zh) 2000-03-01
JPH04217919A (ja) 1992-08-07
CN1056055A (zh) 1991-11-13
EP0454089B1 (en) 1994-08-17
MY115126A (en) 2003-04-30
ES2058977T3 (es) 1994-11-01
ATE109980T1 (de) 1994-09-15
CA2041330C (en) 1996-05-28
JP3170304B2 (ja) 2001-05-28
EP0454089A1 (en) 1991-10-30
PT97505B (pt) 1998-08-31
DE69103459T2 (de) 1995-01-19
DE69103459D1 (de) 1994-09-22
PT97505A (pt) 1992-01-31
CA2041330A1 (en) 1991-10-28
KR910018024A (ko) 1991-11-30
KR930007407B1 (ko) 1993-08-10

Similar Documents

Publication Publication Date Title
ES2094809T3 (es) Composicion absorbible por via percutanea del clorhidrato de morfina.
DK96189D0 (da) Praeparat med nedsat foelsomhed og irritation ved transdermal administration
DE69007592T2 (de) Transdermal absorbierbare Dopaminderivate enthaltende Arzneizubereitungen.
IT1197038B (it) Composizione farmaceutica ad attivita' analgesica
EP0974350A4 (en) EXTERNAL CONTAINING TRANILAST AND METHOD FOR THE PRODUCTION THEREOF
DK0454089T3 (da) Percutant absorberbart eperison- eller tolperisonpræparat
DK90089A (da) Hudbehandlingspraeparat
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
IT1143052B (it) Composizione a base di idrolisato di lattalbumina per il trattamento e la cura della pelle
IT1231509B (it) Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
DE240257T1 (de) Verbindungen und pharmazeutische zusammensetzungen mit kalziumregulierender aktivitaet.
DE59000613D1 (de) Pflaster zur transdermalen anwendung.
ATE59550T1 (de) Chlorpheniramine therapie.
DE69029040D1 (de) Megakaryocytopoietischer faktor
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
FR2607006B1 (fr) Composition pharmaceutique a base d'euphorbia pilulifera et/ou hirta, utilisee notamment comme cicatrisant et/ou desinfectant intestinal
DE3788888T2 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
IT8809003A0 (it) Supporto terapeutico per lungodegenti
ES2054207T3 (es) Metodos de uso de 2-isopropil-2-fenilaminovaleronitrilos como inmunosupresores y vasodilatadores.
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.
NO911470D0 (no) Sammensetning og behandling med biologisk aktive peptiderog visse anioner.
KR890002236U (ko) 의료용 가아제의 증살통
IT8848285A0 (it) Catetere indolore per uomo donna